id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-280221-s6oxq772	Montelongo-Jauregui, Daniel	Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease	2020-08-12		.txt	text/plain	2045	80	36	Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Origin and evolution of pathogenic coronaviruses Bat Coronaviruses in China Remdesivir for the Treatment of Covid-19-Preliminary Report The convalescent sera option for containing COVID-19 Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma Effectiveness of convalescent plasma therapy in severe COVID-19 patients Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19 Treatment with convalescent plasma for COVID-19 patients in Wuhan Convalescent serum lines up as first-choice treatment for coronavirus Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients Ueber das Zustandekommen der Diphtherie-Immunitä t und der Tetanus-Immunitä t bei A pilot study exploring the feasibility of convalescent plasma transfusion to rescue a group of 10 patients with severe disease showed that 1 dose (200 mL) of convalescent plasma with high neutralizing antibody titers was well tolerated, resulted in disappearance of viremia, and improved clinical symptoms in all patients within days of administration [8] .	cache/cord-280221-s6oxq772.txt	txt/cord-280221-s6oxq772.txt
